眼圧計の世界市場：洞察、競合情勢、市場予測：2030年

世界の眼圧計の市場規模は、2023年に3億3,929万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に6.06%のCAGRで拡大し、2030年には5億5,566万米ドルに達すると予測されています。眼圧計の需要は主に、緑内障、高眼圧症、開放隅角緑内障、ぶどう膜炎、角膜疾患、白内障手術、緑内障になりやすい糖尿病人口などの眼科疾患の発生率の上昇によって後押しされています。さらに、眼圧計市場は、世界中で、精度の向上、使いやすさ、患者の快適さなど、多くの技術的進歩により成長すると予測されています。これらは、2024年から2030年までの予測期間中に眼圧計市場のプラス成長に貢献する主な要因です。

緑内障と診断された有病者は2022年に主要7ヶ国で7,045,443人近くと推定されていますが、緑内障の全体的な負担は2022年に主要7ヶ国で16,632,421人近く（有病者）と推定されています。緑内障は、視神経の損傷を特徴とする進行性の眼病であり、眼圧（IOP）の上昇を伴うことが多く、眼圧計による状態の監視と診断が必要であるため、これらのデータと統計は、世界中の眼圧計の将来の市場全体を促進するものと考えられます。

欧州委員会（2023年）によると、2021年、欧州連合（EU）では、白内障手術が主流で、EU諸国全体で432万件の手術が行われました。さらに、同資料によると、2021年の人口10万人当たりの白内障手術率が最も高かったのはフランスで、人口10万人当たり1,417件、次いでオーストリア（人口10万人当たり1,340件）でした。さらに、国際失明予防機関（IAPB）が2020年に実施した調査によると、中等度から重度の白内障に罹患している世界の人口は83,475,182人でした。眼圧計は、白内障手術の術前術後の評価で使用され、眼圧（IOP）の変化を評価・管理するため、これらのデータや統計は、世界中の眼圧計の将来の市場全体に拍車をかけると考えられています。

当レポートでは、世界の眼圧計市場について調査し、市場の概要とともに、装置タイプ別、モビリティ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 眼圧計市場レポートのイントロダクション

第2章 眼圧計市場のエグゼクティブサマリー

• 市場概要

第3章 競合情勢

第4章 規制分析

• 米国
• 欧州
• 日本
• 中国

第5章 眼圧計市場の主要な要因分析

• 眼圧計市場の促進要因
• 眼圧計市場の抑制要因と課題
• 眼圧計市場の機会

第6章 眼圧計市場におけるポーターのファイブフォース分析

第7章 眼圧計市場の評価

• 装置タイプ別
• モビリティ
• エンドユーザー別
• 地域別

第8章 眼圧計市場の企業と製品プロファイル

• Halma Plc
• HAAG-STREIT AG
• Topcon Corporation
• NIDEK CO., LTD
• Reichert, Inc.
• Keeler.
• OCULUS Optikgerate GmbH
• Tomey USA
• CANON MEDICAL SYSTEMS USA, Inc.
• Kowa Company, Ltd.,
• Reichert, Inc.
• AMETEK, Inc.
• NIDEK CO., Ltd.
• Accutome Inc.
• Keeler.
• Itamar Medical Ltd.
• Shenzhen Mindray Bio-Medical Electronics Co Ltd.
• Millar
• DAEYOMEDI
• Alam Medical

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Tonometer Market in Global (2021-2030)
• Table 3: Tonometer Market in Global by Device Type (2021-2030)
• Table 4: Tonometer Market in Global by Mobility (2021-2030)
• Table 5: Tonometer Market in Global by End-User (2021-2030)
• Table 6: Tonometer Market in Global by Geography (2021-2030)
• Table 7: Tonometer Market in North America (2021-2030)
• Table 8: Tonometer Market in North America by Country (2021-2030)
• Table 9: Tonometer Market in the United States (2021-2030)
• Table 10: Tonometer Market in Canada (2021-2030)
• Table 11: Tonometer Market in Mexico (2021-2030)
• Table 12: Tonometer Market in Europe (2021-2030)
• Table 13: Tonometer Market in Europe by Country (2021-2030)
• Table 14: Tonometer Market in France (2021-2030)
• Table 15: Tonometer Market in Germany (2021-2030)
• Table 16: Tonometer Market in the United Kingdom (2021-2030)
• Table 17: Tonometer Market in Italy (2021-2030)
• Table 18: Tonometer Market in Spain (2021-2030)
• Table 19: Tonometer Market in the Rest of Europe (2021-2030)
• Table 20: Tonometer Market in Asia-Pacific (2021-2030)
• Table 21: Tonometer Market in Asia-Pacific by Country (2021-2030)
• Table 22: Tonometer Market in China (2021-2030)
• Table 23: Tonometer Market in Japan (2021-2030)
• Table 24: Tonometer Market in India (2021-2030)
• Table 25: Tonometer Market in Australia (2021-2030)
• Table 26: Tonometer Market in South Korea (2021-2030)
• Table 27: Tonometer Market in Rest of Asia-Pacific (2021-2030)
• Table 28: Tonometer Market in the Rest of the World (2021-2030)
• Table 29: Tonometer Market in RoW by Region (2021-2030)
• Table 30: Tonometer Market in the Middle East (2021-2030)
• Table 31: Tonometer Market in Africa (2021-2030)
• Table 32: Tonometer Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Tonometer Market in Global (2021-2030)
• Figure 3: Tonometer Market in Global by Device Type (2021-2030)
• Figure 4: Tonometer Market in Global by Mobility (2021-2030)
• Figure 5: Tonometer Market in Global by End-User (2021-2030)
• Figure 6: Tonometer Market in Global by Geography (2021-2030)
• Figure 7: Tonometer Market in North America (2021-2030)
• Figure 8: Tonometer Market in North America by Country (2021-2030)
• Figure 9: Tonometer Market in the United States (2021-2030)
• Figure 10: Tonometer Market in Canada (2021-2030)
• Figure 11: Tonometer Market in Mexico (2021-2030)
• Figure 12: Tonometer Market in Europe (2021-2030)
• Figure 13: Tonometer Market in Europe by Country (2021-2030)
• Figure 14: Tonometer Market in France (2021-2030)
• Figure 15: Tonometer Market in Germany (2021-2030)
• Figure 16: Tonometer Market in the United Kingdom (2021-2030)
• Figure 17: Tonometer Market in Italy (2021-2030)
• Figure 18: Tonometer Market in Spain (2021-2030)
• Figure 19: Tonometer Market in the Rest of Europe (2021-2030)
• Figure 20: Tonometer Market in Asia-Pacific (2021-2030)
• Figure 21: Tonometer Market in Asia-Pacific by Country (2021-2030)
• Figure 22: Tonometer Market in China (2021-2030)
• Figure 23: Tonometer Market in Japan (2021-2030)
• Figure 24: Tonometer Market in India (2021-2030)
• Figure 25: Tonometer Market in Australia (2021-2030)
• Figure 26: Tonometer Market in South Korea (2021-2030)
• Figure 27: Tonometer Market in Rest of Asia-Pacific (2021-2030)
• Figure 28: Tonometer Market in the Rest of the World (2021-2030)
• Figure 29: Tonometer Market in RoW by Region (2021-2030)
• Figure 30: Tonometer Market in the Middle East (2021-2030)
• Figure 31: Tonometer Market in Africa (2021-2030)
• Figure 32: Tonometer Market in South America (2021-2030)
• Figure 33: Market Drivers
• Figure 34: Market Barriers
• Figure 35: Marker Opportunities
• Figure 36: PORTER'S Five Force Analysis

Tonometer Market By Device Types (Applanation {Goldman Tonometer, Perkins Applanation Tonometer, And Others}, Indentation Tonometers, Non- Contact Tonometer, Rebound Tonometer, Dynamic Contour Tonometer), Portability (Desktop Tonometer, Hand-Held Tonometer), End- User (Hospitals, Opthalmic Clinic, And Others), And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady cagr forecast till 2030 owing to the rising prevelance of opthalmic disorders such as glaucoma, ocular hypertension, uveitis, corneal disorders, cataract surgery, and technological advancement across the globe.

The global Tonometer market was valued at USD 339.29 million in 2023, growing at a CAGR of 6.06% during the forecast period from 2024 to 2030 to reach USD 505.66 million by 2030. The demand for tonometers is primarily being boosted by the growing incidence of ophthalmic disorders such as glaucoma, ocular hypertension, open-angle glaucoma, uveitis, corneal disorders, cataract surgery, and the diabetic population who are more prone to glaucoma. Furthermore, the tonometer market is anticipated to grow on account of a large number of technological advancements such as improved accuracy, ease of use, and patient comfort across the globe. These are the major drivers that are responsible for contributing to the positive growth of the tonometer market during the forecast period from 2024-2030.

Tonometer Market Dynamics:

According, to the estimates of DelveInsight the total glaucoma diagnosed prevalent cases were estimated at nearly 7,045,443 cases in 2022 in the 7MM, however the overall burden of glaucoma has been estimated to be nearly 16,632,421 (Prevalent cases) in 2022 in the 7MM. Hence, these data and stats are accepted to fuel the overall future market of tonometers across the globe as glaucoma is a progressive eye disease characterized by damage to the optic nerve, often associated with elevated intraocular pressure (IOP) and requires a tonometer for monitoring and diagnosing the conditions.

According to the European Commission (2023), in 2021, the European Union saw cataract surgery as the predominant surgical procedure, with a significant 4.32 million operations performed across EU nations. Additionally, as per the same source France had the highest rate of cataract surgery per 100,000 population in 2021 estimating 1,417 per 100,000 population followed by Austria (1,340 PER 100,000 population). Furthermore, as per the study conducted by the International Agency for the Prevention of Blindness (IAPB) in 2020, the global population affected by moderate to severe cataracts was 83,475,182. These data and stats are accepted to fuel the overall future market of tonometer across the globe as tonometers are used during pre-operative and post-operative assessment of cataract surgery to assess and manage the changes in Intraocular pressure (IOP).

Furthermore, tonometers can be used as part of the overall assessment of diabetic eye disease and its complications. Additionally, as per the study conducted by the International Agency for the Prevention of Blindness (IAPB) in 2020, the global population affected by moderate to severe diabetic retinopathy was 3,278,034. Diabetic retinopathy is a complication of diabetes affecting the eyes and needs regular eye checkups including IOP measurements. Hence, the prevalence and incidence rates of ocular diseases such as glaucoma, cataract surgery, and diabetes retinopathy highlight the future significant market growth of tonometer.

Further, the continuous advancements in tonometry technology are driving the overall market of tonometers. In November 2022, NIDEK has introduced the NT-1p non-contact Tono/Pachymeter, an innovative device designed to automate both reliable non-contact tonometry and pachymetry. This advanced technology automatically detects the position of the eyes, initiating measurements without the need for manual button presses. This streamlined approach enhances efficiency and user experience, making the device particularly convenient for eye care professionals conducting intraocular pressure and corneal thickness assessments. Additionally, the growing awareness about the importance of regular eye check-ups and early detection of eye diseases is also contributing to fueling the current demand for tonometers.

However, the risk of infection with contact tonometers and lack of accuracy in non-contact tonometers during checkups may hinder the market demand for tonometers.

Tonometer Market Segment Analysis:

Tonometer Market by Device Types (Applanation {Goldman Tonometer, Perkins Applanation Tonometer, and Others}), Indentation Tonometers, Non-Contact Tonometer, Rebound Tonometer, Dynamic Contour Tonometer), Portability (Desktop Tonometer, Hand-Held Tonometer), End-User (Hospitals, Ophthalmic Clinic, And Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product segment of the tonometer market, the applanation tonometer category is estimated to have a significant revenue share in the tonometer market in 2023. This can be attributed to the various advantages and applications provided by the applanation tonometer. These devices are used to measure the intraocular pressure (IOP) by flattening a small area of the cornea and are considered one of the most accurate methods of measuring IOP. Applanation tonometers with non-contact options offer similar accuracy to contact tonometers. Some applanation tonometers, such as the Goldman tonometer, can be used in a non-contact mode, reducing the risk of corneal abrasions or infections associated with contact methods. Besides this, the absence of the need for fluorescein dye instillation or tropical anesthesia during tonometer use simplifies the procedure and enhances safety. All these advanced features of applanation tonometer are promoting the growth of overall tonometers. Applanation tonometers provide a direct measurement of IOP by directly assessing the cornea's response to pressure. Thus resulting in a more objective and accurate measurement of intraocular pressure.

Hence, the applanation tonometer is regarded as the gold standard for measuring IOP, and it's user-friendly and relatively easy operation, requiring minimal training for healthcare professionals will contribute to the growth of the overall tonometer market during the forecast period.

North America Is Expected To Dominate The Overall Tonometer Market:

North America is expected to account for the highest proportion of the global tonometer market in 2023, out of all regions. This is due to the presence of a large patient pool suffering from an ophthalmic disorder such as glaucoma, ocular hypertension, open angle glaucoma, uveitis, corneal disorders, cataract surgery, diabetic population who are more prone to glaucoma, and technological advancement.

According to the data provided by the Centers for Disease Control and Prevention (CDC) (2023), in 2021, in the United States, among people with diabetes, the prevalence rate of diabetes retinopathy was lowest among people younger than age 25 at 13.0% and highest among the 65-79 age group at 28.4%. Thus tonometer can be used to monitor IOP regularly in diabetic patients to detect any potential changes in IOP that may indicate the presence of glaucoma alongside diabetic retinopathy.

According to the latest data provided by the Centers for Disease Control and Prevention (CDC) (2020), glaucoma affects approximately 3 million Americans and ranks as the second leading cause of blindness globally. As per the same source, the number of glaucoma patients is expected to rise to 6.3 million by 2050 in America. The open-angle glaucoma, the predominant form is characterized by elevated eye pressure, often occurring without early symptoms and leaving 50% of affected individuals unaware of their condition. As a result, these statistics and data are expected to fuel the future market of tonometer devices in North America as intraocular pressure (IOP) monitoring is important in ocular disease to assess and manage the changes in IOP.

Furthermore, recent strategic initiatives and various product approvals of tonometers are also aiding in driving the market growth of tonometer devices in the region. In March 2022, Icare attained 510(k) clearance from the FDA in the United States for their latest self-tonometer iteration, the iCare HOME2. This innovative device is designed to simplify the process of measuring patients' intraocular pressure (IOP) beyond regular clinic hours, aiming to aid in the management of glaucoma. Thus the new product approval with advanced technologies is driving the market growth of tonometer in North America.

Additionally, the increase in the rising awareness programs by government authorities are also facilitating the overall use of tonometers thus increasing the future market of tonometer in the United States. Several government authorities in America such as the National Eye Health Education Program (NEHEP), in coordination with the National Eye Institute (NEI) of the National Institutes of Health (NIH) promotes eye health awareness across the United States like Glaucoma Awareness Month. Thus, the increased eye care awareness programs are contributing to market growth of tonometer In North America.

Tonometer Market Key Players:

Some of the key market players operating in the Tonometer include Ziemer Ophthalmic Systems AG, Haag- streit, Topcon Corporation, NIDEK CO., LTD, Reichert, Inc., Keeler., OCULUS Optikgerate GmbH, Tomey USA, Canon medical systems USA, Inc., Kowa Company, Ltd., Reichert, Inc., Ametek, Inc., Nidek CO., Ltd., Accutome Inc., Keeler., Itamar Medical Ltd., Shenzhen Mindray Bio-Medical Electronics Co Ltd., Millar, DAEYOMEDI, Alam Medical.

Recent Developmental Activities In The Tonometer Market:

• In May 2023 marked the launch of the Tono-Vera(R) Tonometer by Reichert Technologies, a subsidiary of AMETEK, Inc. This handheld tonometer, equipped with the ActiView(TM) Positioning System, stands out for its ability to deliver fast and dependable measurements of intraocular pressure, reinforcing Reichert's reputation as a global leader in eye care diagnostic devices.

Key Takeaways From The Tonometer Market Report Study

• Market size analysis for current Tonometer Market size (2023), and market forecast for 6 years (2024-2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global Tonometer market.
• Various opportunities available for the other competitors in the Tonometer Market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current Tonometer market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Tonometer market growth in the coming future?

Target Audience Who Can Be Benefited From This Tonometer Market Report Study

• Tonometer product providers
• Research organizations and consulting companies
• Cardiac Restoration Systems-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in Tonometer
• Various end-users who want to know more about the Tonometer Market and the latest technological developments in the Tonometer Market.

Frequently Asked Questions For The Tonometer Market:

1. What are Tonometer?

A tonometer is a medical device used to measure the intraocular pressure (IOP) within the eye. Intraocular pressure refers to the fluid pressure inside the eye, which is primarily determined by the balance between the production and drainage of aqueous humor, the clear fluid that fills the anterior chamber of the eye.

2. What is the market for Tonometer?

The global Tonometer market was valued at USD 339.29 million in 2023, growing at a CAGR of 6.06% during the forecast period from 2024 to 2030 to reach USD 505.66 million by 2030.

3. What are the drivers for the global Tonometer market?

The demand for tonometers is primarily being boosted by the growing incidence of ophthalmic disorders such as glaucoma, ocular hypertension, open angle glaucoma, uveitis, corneal disorders, cataract surgery, and diabetic population who are more prone to glaucoma. Furthermore, the tonometer market is anticipated to grow on account of a large number of technological advancements such as improved accuracy, ease of use, and patient comfort across the globe. These are the major drivers that are responsible for contributing to the positive growth of the Tonometer market during the forecast period from 2024-2030.

4. Who are the key players operating in the global Tonometer market?

Some of the key market players operating in the Tonometer included Halma Plc, Haag- streit, Topcon Corporation, Nidek Co., Ltd, Reichert, Inc., Keeler., Oculus Optikgerate GmbH, Tomey USA, Canon medical systems USA, Inc., Kowa Company, Ltd., Reichert, Inc., Ametek, Inc., Nidek Co., Ltd., Accutome Inc., Keeler., Itamar Medical Ltd., Shenzhen Mindray Bio-Medical Electronics Co Ltd., Millar, Daeyomedi, Alam Medical.

5. Which region has the highest share in the global Tonometer market?

North America is expected to account for the highest proportion of the tonometer Market in 2023, out of all regions. This is due to the presence of a large patient pool suffering from an ophthalmic disorder such as glaucoma, ocular hypertension, open angle glaucoma, uveitis, corneal disorders, cataract surgery, diabetic population who are more prone to glaucoma, and technological advancement in tonometers are some other major factors that are responsible in contributing to the positive growth of the tonometer market in North America.

Table of Contents

1. Tonometer Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Tonometer Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Tonometer Market Key Factors Analysis

• 5.1. Tonometer Market Drivers
  • 5.1.1. Rising prevalence of ophthalmic disorders such as glaucoma and others
  • 5.1.2. Innovation in technology
  • 5.1.3. Increasing awareness and screening programs
• 5.2. Tonometer Market Restraints and Challenges
  • 5.2.1. Risk of infection in contact tonometers.
  • 5.2.2. Lack of accuracy in non-contact tonometers.
• 5.3. Tonometer Market Opportunities
  • 5.3.1. Ongoing advancements in tonometry technology.

6. Tonometer Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Tonometer Market Assessment

• 7.1. By Device Type
  • 7.1.1. Applanation Tonometer
    • 7.1.1.1. Goldman Tonometer
    • 7.1.1.2. Perkins Applanation Tonometer
    • 7.1.1.3. Others
  • 7.1.2. Indentation Tonometers
  • 7.1.3. Non-Contact Tonometer
  • 7.1.4. Rebound Tonometer
  • 7.1.5. Dynamic Contour Tonometer
• 7.2. By Mobility
  • 7.2.1. Desktop Tonometer
  • 7.2.2. Hand-Held Tonometer
• 7.3. By End-User
  • 7.3.1. Hospitals
  • 7.3.2. Ophthalmic Clinics
  • 7.3.3. Others
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. United States Tonometer Market Size in USD million (2021-2030)
    • 7.4.1.2. Canada Tonometer Market Size in USD million (2021-2030)
    • 7.4.1.3. Mexico Tonometer Market Size in USD million (2021-2030)
  • 7.4.2. Europe
    • 7.4.2.1. France Tonometer Market Size in USD million (2021-2030)
    • 7.4.2.2. Germany Tonometer Market Size in USD million (2021-2030)
    • 7.4.2.3. United Kingdom Tonometer Market Size in USD million (2021-2030)
    • 7.4.2.4. Italy Tonometer Market Size in USD million (2021-2030)
    • 7.4.2.5. Spain Tonometer Market Size in USD million (2021-2030)
    • 7.4.2.6. Rest of Europe Tonometer Market Size in USD million (2021-2030)
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. China Tonometer Market Size in USD million (2021-2030)
    • 7.4.3.2. Japan Tonometer Market Size in USD million (2021-2030)
    • 7.4.3.3. India Tonometer Market Size in USD million (2021-2030)
    • 7.4.3.4. Australia Tonometer Market Size in USD million (2021-2030)
    • 7.4.3.5. South Korea Tonometer Market Size in USD million (2021-2030)
    • 7.4.3.6. Rest of Asia-Pacific Tonometer Market Size in USD million (2021-2030)
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. Middle East Tonometer Market Size in USD million (2021-2030)
    • 7.4.4.2. Africa Tonometer Market Size in USD million (2021-2030)
    • 7.4.4.3. South America Tonometer Market Size in USD million (2021-2030)

8. Tonometer Market Company and Product Profiles

• 8.1. Halma Plc
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. HAAG-STREIT AG
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Topcon Corporation
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. NIDEK CO., LTD
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Reichert, Inc.
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Keeler.
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. OCULUS Optikgerate GmbH
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. Tomey USA
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. CANON MEDICAL SYSTEMS USA, Inc.
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. Kowa Company, Ltd.,
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Reichert, Inc.
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. AMETEK, Inc.
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. NIDEK CO., Ltd.
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. Accutome Inc.
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. Keeler.
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. Itamar Medical Ltd.
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy
• 8.17. Shenzhen Mindray Bio-Medical Electronics Co Ltd.
  • 8.17.1. Company Overview
  • 8.17.2. Company Snapshot
  • 8.17.3. Financial Overview
  • 8.17.4. Product Listing
  • 8.17.5. Entropy
• 8.18. Millar
  • 8.18.1. Company Overview
  • 8.18.2. Company Snapshot
  • 8.18.3. Financial Overview
  • 8.18.4. Product Listing
  • 8.18.5. Entropy
• 8.19. DAEYOMEDI
  • 8.19.1. Company Overview
  • 8.19.2. Company Snapshot
  • 8.19.3. Financial Overview
  • 8.19.4. Product Listing
  • 8.19.5. Entropy
• 8.20. Alam Medical
  • 8.20.1. Company Overview
  • 8.20.2. Company Snapshot
  • 8.20.3. Financial Overview
  • 8.20.4. Product Listing
  • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us